Salient Surgical Technologies

Portsmouth, United States Founded: 1999 • Age: 27 yrs Acquired By Medtronic
Electrosurgical systems for surgical resections and procedures are developed.
Request Access

About Salient Surgical Technologies

Salient Surgical Technologies is a company based in Portsmouth (United States) founded in 1999 was acquired by Medtronic in July 2011.. Salient Surgical Technologies has raised $120.5 million across 7 funding rounds from investors including Medtronic, Legacy Health and BMO Global Asset Management. Salient Surgical Technologies operates in a competitive market with competitors including Sequana Medical, Yaqrit, CalmiGo, Xlumena and Autem Therapeutics, among others.

  • Headquarter Portsmouth, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Salient Surgical Technologies Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $120.5 M (USD)

    in 7 rounds

  • Latest Funding Round
    $15.1 M (USD), Series G

    Jan 25, 2010

  • Investors
    Medtronic

    & 17 more

  • Employee Count
    Employee Count
  • Acquired by
    Medtronic

    (Jul 07, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Salient Surgical Technologies

Salient Surgical Technologies has successfully raised a total of $120.5M across 7 strategic funding rounds. The most recent funding activity was a Series G round of $15.1 million completed in January 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series G — $15.1M
  • First Round

    (01 Oct 2000)

  • Investors Count 18
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2010 Amount Series G - Salient Surgical Technologies Valuation

investors

Mar, 2009 Amount Series F - Salient Surgical Technologies Valuation

investors

Oct, 2008 Amount Series F - Salient Surgical Technologies Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Salient Surgical Technologies

Salient Surgical Technologies has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Legacy Health and BMO Global Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Expansion stage tech-focused VC firm investing primarily in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Salient Surgical Technologies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Salient Surgical Technologies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Salient Surgical Technologies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Salient Surgical Technologies

Salient Surgical Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, Yaqrit, CalmiGo, Xlumena and Autem Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Implantable battery-powered pumps for ascites removal are developed.
domain founded_year HQ Location
Liver dialysis devices for treating cirrhosis and failure are developed.
domain founded_year HQ Location
Stress-relief devices are developed using smart breathing regulation technology.
domain founded_year HQ Location
Image-guided therapeutic endoscopy devices are developed for medical procedures.
domain founded_year HQ Location
Bioelectric platforms for cancer treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Salient Surgical Technologies

Frequently Asked Questions about Salient Surgical Technologies

When was Salient Surgical Technologies founded?

Salient Surgical Technologies was founded in 1999 and raised its 1st funding round 1 year after it was founded.

Where is Salient Surgical Technologies located?

Salient Surgical Technologies is headquartered in Portsmouth, United States. It is registered at Portsmouth, Virginia, United States.

Who is the current CEO of Salient Surgical Technologies?

Geoffery Martha is the current CEO of Salient Surgical Technologies.

Is Salient Surgical Technologies a funded company?

Salient Surgical Technologies is a funded company, having raised a total of $120.5M across 7 funding rounds to date. The company's 1st funding round was a Series F of $17.9M, raised on Oct 01, 2000.

What does Salient Surgical Technologies do?

Founded in 1999 in Portsmouth, United States, electrosurgical systems for medical applications were developed by Salient Surgical Technologies. Initial focus was placed on monopolar devices used in liver and pancreatic resections. Subsequent products included the bipolar AQUAMANTYS System, applied in orthopaedic reconstruction, spine surgery, trauma, and oncology. Acquisition by Medtronic occurred in 2011, integrating these technologies into broader surgical solutions.

Who are the top competitors of Salient Surgical Technologies?

Salient Surgical Technologies's top competitors include Sequana Medical, Yaqrit and CalmiGo.

Who are Salient Surgical Technologies's investors?

Salient Surgical Technologies has 18 investors. Key investors include Medtronic, Legacy Health, BMO Global Asset Management, Piper Jaffray, and Brait.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available